Bonk (BNKK) risk factors, FY2024 10-K

Risks Related to Our Business

1. 01If we are unable to keep up with rapid technological changes, our products may become obsolete
2. 02Competition could adversely affect our business
3. 03If we are unable to develop and maintain our brand and reputation for our product offerings, our business and prospects could be materially harmed
4. 04We are subject to government regulation, and unfavorable changes could substantially harm our business and results of operations
5. 05We depend heavily on key personnel, and turnover of key senior management could harm our business
6. 06Our products may not meet health and safety standards or could become contaminated
7. 07The sale of our products involves product liability and related risks that could expose us to significant insurance and loss expenses
8. 08The success of our business will depend upon our ability to create and expand our brand awareness
9. 09We must develop and introduce new products to succeed
10. 10Adverse publicity associated with our products or ingredients, or those of similar companies, could adversely affect our sales and revenue
11. 11If serious adverse or undesirable side effects are identified during the development of our product candidates, we may abandon or limit our development or commercialization of such product candidates
12. 12It is uncertain whether product liability insurance will be adequate to address product liability claims, or that insurance against such claims will be affordable or available on acceptable terms in the future
13. 13If we are unable to establish relationships with licensees or collaborators to carry out sales, marketing, and distribution functions or to create effective marketing, sales, and distribution capabilities, we will be unable to market our products successfully
14. 14Natural disasters and other events beyond our control could materially adversely affect us
15. 15We have a limited operating history upon which investors can evaluate our future prospects
16. 16We are subject to government regulations of the processing, formulation, packaging, labeling and advertising of our wellness and dietary supplement products
17. 17Our failure to comply with applicable laws or regulations could result in substantial monetary penalties and could adversely affect our operating results
18. 18Our reliance on third parties to manufacture and supply our products, including the Sure Shot Dietary Supplement, may harm our business, financial condition and operating results
19. 19We may not meet our product development and commercialization milestones
20. 20Our operations in international markets involve inherent risks that we may not be able to control
21. 21Compliance with new and existing laws and governmental regulations could increase our costs significantly and adversely affect our results of operations
22. 22International trade disputes, including U.S. trade tariffs and retaliatory tariffs, could adversely impact our business
23. 23Significant political, trade, regulatory developments, and other circumstances beyond our control, could have a material adverse effect on our financial condition or results of operations
24. 24Regulatory changes or actions may alter the nature of an investment in us or restrict the use of cryptocurrencies in a manner that adversely affects our business, prospects, or operations
25. 25Our business, operations, financial position and timelines, could be materially adversely affected by the continuing military action in Ukraine and the war between Israel and Hamas

Risks Related to our Financial Position and Capital Needs

1. 26Our accountant has indicated doubt about our ability to continue as a going concern
2. 27Raising additional capital may cause dilution to our existing stockholders, restrict our operations or require us to relinquish rights to our technologies or other assets
3. 28Changes in tax laws and unanticipated tax liabilities could adversely affect our effective income tax rate and ability to achieve profitability

Risks Related to our Intellectual Property

1. 29We may incur substantial costs as a result of litigation or other proceedings relating to patent and other intellectual property rights
2. 30A third party may sue us or one of our strategic collaborators for infringing its intellectual property rights. Likewise, we may need to resort to litigation to enforce licensed rights or to determine the scope and validity of third-party intellectual property rights
3. 31Any inability to protect our intellectual property rights could reduce the value of our products and brands, which could adversely affect our financial condition, results of operations and business
4. 32The intellectual property behind our products may include unpublished know-how as well as existing and pending intellectual property protection. All intellectual property protection eventually expires, and unpublished know-how is dependent on key individuals
5. 33If we are not able to adequately protect our intellectual property, then we may not be able to compete effectively, and we may not be profitable

Risks Related to Our Securities and Other Risks

1. 34We are an “emerging growth company” and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors
2. 35We have broad discretion in the use of the net proceeds from any offerings and may not use them effectively
3. 36Our management has limited experience in managing the day-to-day operations of a public company and, as a result, we may incur additional expenses associated with the management of our Company
4. 37Compliance with changing corporate governance regulations and public disclosures may result in additional risks and exposures
5. 38Certain of our stockholders hold a significant percentage of our outstanding voting securities, which could reduce the ability of minority stockholders to effect certain corporate actions
6. 39If securities or industry analysts publish inaccurate or unfavorable research about our business, our stock price could decline
7. 40Our Second Amended and Restated Certificate of Incorporation contains an exclusive forum provision for certain claims, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees
8. 41Our issuance of additional common stock or preferred stock may cause our common stock price to decline, which may negatively impact your investment
9. 42Anti-takeover provisions in the Company’s charter and bylaws may prevent or frustrate attempts by stockholders to change the board of directors or current management and could make a third-party acquisition of the Company difficult
10. 43Our common stock may become subject to the SEC’s penny stock rules and accordingly, broker-dealers may experience difficulty in completing customer transactions and trading activity in our securities may be adversely affected